Schwartz Lab

Publications

Siddiqui, S; Wenzel, SE; Bozik, ME; Archibald, DG; Dworetzky, SI; Mather, JL; Killingsworth, R; Ghearing, N; Schwartz, JT; Ochkur, SI; Jacobsen, EA; Busse, WW; Panettieri, RA; Prussin, C. Safety and Efficacy of Dexpramipexole in Eosinophilic Asthma (EXHALE): A randomized controlled trial. Journal of Allergy and Clinical Immunology. 2023; 152:1121-1130.e10.

Kliewer, KL; Murray-Petzold, C; Collins, MH; Abonia, JP; Bolton, SM; DiTommaso, LA; Martin, LJ; Zhang, X; Mukkada, VA; Putnam, PE; Lyles, JL; Shoda, T; Klion, AD; Rothenberg, ME. Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet Gastroenterology and Hepatology. 2023; 8:803-815.

Guarnieri, KM; Saba, NK; Schwartz, JT; Devonshire, AL; Bufford, J; Casale, TB; Rothenberg, ME; Andorf, S. Food Allergy Characteristics Associated With Coexisting Eosinophilic Esophagitis in FARE Registry Participants. Journal of Allergy and Clinical Immunology: In Practice. 2023; 11:1509-1521.e6.

Gill, K; Moore, C; Nwogu, O; Kroner, JW; Chang, W; Stevens, ML; Kyzy, AB; Biagini, JM; Devonshire, AL; Kottyan, L; Martin, LJ; Andorf, S; Hershey, GK K; Roskin, KM. B cell repertoire in children with skin barrier dysfunction supports altered IgE maturation associated with allergic food sensitization. 2023; 4:2023.02.01.526538.

Underwood, B; Troutman, TD; Schwartz, JT. Breaking down the complex pathophysiology of eosinophilic esophagitis. Annals of Allergy, Asthma, and Immunology. 2023; 130:28-39.

Dill-McFarland, KA; Schwartz, JT; Zhao, H; Shao, B; Fulkerson, PC; Altman, MC; Gill, MA. Eosinophil-mediated suppression and anti-IL-5 enhancement of plasmacytoid dendritic cell interferon responses in asthma. Journal of Allergy and Clinical Immunology. 2022; 150:666-675.

Wright, BL; Schwartz, JT; Ruffner, MA; Furuta, GT; Gonsalves, N; Dellon, ES; Aceves, SS. Eosinophilic gastrointestinal diseases make a name for themselves: A new consensus statement with updated nomenclature. Journal of Allergy and Clinical Immunology. 2022; 150:291-293.

Droghini, HR; Abonia, JP; Collins, MH; Milner, JD; Lyons, JJ; Freeman, AF; Mukkada, VA; Risma, KA; Rothenberg, ME; Schwartz, JT. Targeted IL-4Rα blockade ameliorates refractory allergic eosinophilic inflammation in a patient with dysregulated TGF-β signaling due to ERBIN deficiency. Journal of Allergy and Clinical Immunology: In Practice. 2022; 10:1903-1906.

Felton, JM; Bouffi, C; Schwartz, JT; Schollaert, KL; Malik, A; Vallabh, S; Wronowski, B; Magier, AZ; Merlin, L; Barski, A; Weirauch, MT; Fulkerson, PC; Rothenberg, ME. Aiolos regulates eosinophil migration into tissues. Mucosal Immunology. 2021; 14:1271-1281.

Slack, IF; Schwartz, JT; Mukkada, VA; Hottinger, S; Abonia, JP. Eosinophilic Esophagitis: Existing and Upcoming Therapies in an Age of Emerging Molecular and Personalized Medicine. Current Allergy and Asthma Reports. 2020; 20:30.

Lindsley, AW; Schwartz, JT; Rothenberg, ME. Eosinophil responses during COVID-19 infections and coronavirus vaccination. Journal of Allergy and Clinical Immunology. 2020; 146:1-7.

Henderson, A; Magier, A; Schwartz, JT; Martin, LJ; Collins, MH; Putnam, PE; Mukkada, VA; Abonia, JP; Rothenberg, ME; Fulkerson, PC. Monitoring Eosinophilic Esophagitis Disease Activity With Blood Eosinophil Progenitor Levels. Journal of Pediatric Gastroenterology and Nutrition. 2020; 70:482-488.

Mbae, M; Owen, L; Elisha, KK; Ndhere, A; Mugambi, NS; Yogev, R; Murphy, RL; Jarvis, JN. Excess early mortality in HIV/hepatitis B virus co-infected patients initiating antiretroviral therapy in Kenya. AIDS. 2019; 33:1404-1406.